An unusual case of hürthle cell carcinoma presenting as metastatic pleural disease 16 years after thyroidectomy

Nadine Bagherzadegan, David Feller-Kopman, Armin Ernst, Stephan Haerle, William Lunn

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Hürthle cell carcinoma (HCC), a variant of a follicular carcinoma of the thyroid, is an aggressive type of differentiated thyroid cancer now considered a distinct pathologic entity. It may present as a low-grade tumor or as a more aggressive type. Prognosis depends on the age of the patient, tumor size, extent of invasion, and initial nodal or distant metastasis. Although thoracic involvement is not unusual with this tumor, this is the first report, to our knowledge, of latent pleural and lung metastases that were detected by a thoracentesis. PATIENT AND METHODS: A 63-year-old woman underwent total thyroidectomy for a thyroid mass in 1990 that was diagnosed as HCC. In December 2006, she presented with symptoms of dyspnea and an abnormal chest x-ray. A subsequent ultrasound-guided thoracentesis revealed a malignant, exudative effusion. Cytopathologic analysis revealed the malignancy to be consistent with HCC. She was reevaluated by her original oncologist and is undergoing treatment for metastatic HCC. CONCLUSIONS: Although rare, HCC may present years after definitive therapy as metastatic pleural and lung disease. Further studies are needed to determine the cause of latency in such cases.

Original languageEnglish (US)
Pages (from-to)204-206
Number of pages3
JournalJournal of Bronchology and Interventional Pulmonology
Volume16
Issue number3
DOIs
StatePublished - Jul 2009

Fingerprint

Pleural Diseases
Thyroidectomy
Carcinoma
Neoplasms
Thorax
Follicular Adenocarcinoma
Neoplasm Metastasis
Thyroid Neoplasms
Dyspnea
Lung Diseases
Thyroid Gland
X-Rays
Lung
Therapeutics

Keywords

  • Hürthle cell carcinoma
  • Metastasis
  • Pleural space
  • Recurrence
  • Thoracentesis
  • Thyroid cancer

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

An unusual case of hürthle cell carcinoma presenting as metastatic pleural disease 16 years after thyroidectomy. / Bagherzadegan, Nadine; Feller-Kopman, David; Ernst, Armin; Haerle, Stephan; Lunn, William.

In: Journal of Bronchology and Interventional Pulmonology, Vol. 16, No. 3, 07.2009, p. 204-206.

Research output: Contribution to journalArticle

@article{9c10e576c4404dd6a8d8cb34222026d9,
title = "An unusual case of h{\"u}rthle cell carcinoma presenting as metastatic pleural disease 16 years after thyroidectomy",
abstract = "BACKGROUND: H{\"u}rthle cell carcinoma (HCC), a variant of a follicular carcinoma of the thyroid, is an aggressive type of differentiated thyroid cancer now considered a distinct pathologic entity. It may present as a low-grade tumor or as a more aggressive type. Prognosis depends on the age of the patient, tumor size, extent of invasion, and initial nodal or distant metastasis. Although thoracic involvement is not unusual with this tumor, this is the first report, to our knowledge, of latent pleural and lung metastases that were detected by a thoracentesis. PATIENT AND METHODS: A 63-year-old woman underwent total thyroidectomy for a thyroid mass in 1990 that was diagnosed as HCC. In December 2006, she presented with symptoms of dyspnea and an abnormal chest x-ray. A subsequent ultrasound-guided thoracentesis revealed a malignant, exudative effusion. Cytopathologic analysis revealed the malignancy to be consistent with HCC. She was reevaluated by her original oncologist and is undergoing treatment for metastatic HCC. CONCLUSIONS: Although rare, HCC may present years after definitive therapy as metastatic pleural and lung disease. Further studies are needed to determine the cause of latency in such cases.",
keywords = "H{\"u}rthle cell carcinoma, Metastasis, Pleural space, Recurrence, Thoracentesis, Thyroid cancer",
author = "Nadine Bagherzadegan and David Feller-Kopman and Armin Ernst and Stephan Haerle and William Lunn",
year = "2009",
month = "7",
doi = "10.1097/LBR.0b013e3181b01521",
language = "English (US)",
volume = "16",
pages = "204--206",
journal = "Journal of Bronchology and Interventional Pulmonology",
issn = "1944-6586",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - An unusual case of hürthle cell carcinoma presenting as metastatic pleural disease 16 years after thyroidectomy

AU - Bagherzadegan, Nadine

AU - Feller-Kopman, David

AU - Ernst, Armin

AU - Haerle, Stephan

AU - Lunn, William

PY - 2009/7

Y1 - 2009/7

N2 - BACKGROUND: Hürthle cell carcinoma (HCC), a variant of a follicular carcinoma of the thyroid, is an aggressive type of differentiated thyroid cancer now considered a distinct pathologic entity. It may present as a low-grade tumor or as a more aggressive type. Prognosis depends on the age of the patient, tumor size, extent of invasion, and initial nodal or distant metastasis. Although thoracic involvement is not unusual with this tumor, this is the first report, to our knowledge, of latent pleural and lung metastases that were detected by a thoracentesis. PATIENT AND METHODS: A 63-year-old woman underwent total thyroidectomy for a thyroid mass in 1990 that was diagnosed as HCC. In December 2006, she presented with symptoms of dyspnea and an abnormal chest x-ray. A subsequent ultrasound-guided thoracentesis revealed a malignant, exudative effusion. Cytopathologic analysis revealed the malignancy to be consistent with HCC. She was reevaluated by her original oncologist and is undergoing treatment for metastatic HCC. CONCLUSIONS: Although rare, HCC may present years after definitive therapy as metastatic pleural and lung disease. Further studies are needed to determine the cause of latency in such cases.

AB - BACKGROUND: Hürthle cell carcinoma (HCC), a variant of a follicular carcinoma of the thyroid, is an aggressive type of differentiated thyroid cancer now considered a distinct pathologic entity. It may present as a low-grade tumor or as a more aggressive type. Prognosis depends on the age of the patient, tumor size, extent of invasion, and initial nodal or distant metastasis. Although thoracic involvement is not unusual with this tumor, this is the first report, to our knowledge, of latent pleural and lung metastases that were detected by a thoracentesis. PATIENT AND METHODS: A 63-year-old woman underwent total thyroidectomy for a thyroid mass in 1990 that was diagnosed as HCC. In December 2006, she presented with symptoms of dyspnea and an abnormal chest x-ray. A subsequent ultrasound-guided thoracentesis revealed a malignant, exudative effusion. Cytopathologic analysis revealed the malignancy to be consistent with HCC. She was reevaluated by her original oncologist and is undergoing treatment for metastatic HCC. CONCLUSIONS: Although rare, HCC may present years after definitive therapy as metastatic pleural and lung disease. Further studies are needed to determine the cause of latency in such cases.

KW - Hürthle cell carcinoma

KW - Metastasis

KW - Pleural space

KW - Recurrence

KW - Thoracentesis

KW - Thyroid cancer

UR - http://www.scopus.com/inward/record.url?scp=68949144643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68949144643&partnerID=8YFLogxK

U2 - 10.1097/LBR.0b013e3181b01521

DO - 10.1097/LBR.0b013e3181b01521

M3 - Article

C2 - 23168555

AN - SCOPUS:68949144643

VL - 16

SP - 204

EP - 206

JO - Journal of Bronchology and Interventional Pulmonology

JF - Journal of Bronchology and Interventional Pulmonology

SN - 1944-6586

IS - 3

ER -